PR

MEZOO, connecting health through technology
Sharing MEZOO’s technology and vision.
External
2025.11.04
Bupyeong Serim Hospital Director Moon-Sul Yang “After Introducing HiCardi, Trust Between Patients and Medical Staff Has Increased”

 

[HiCardi KOL Interview] ③

“Just Knowing That Medical Staff Are Monitoring a Patient’s ECG 24 Hours a Day Gives Patients Peace of Mind”

 

Real-Time Remote Patient Monitoring Solution “HiCardi” KOL Interview

 

HiCardi is a smart patch worn on the chest that measures electrocardiograms without the need for complex wired equipment. Through a cloud-based system, medical staff can remotely monitor patients’ vital sign data in real time anytime and anywhere. This reduces the workload of healthcare professionals while enabling more efficient patient management. The solution is currently widely used for cardiac disease screening across various medical settings, including clinics, long-term care hospitals, and general hospitals, and continues to bed and enhanced.

 

Through a KOL (Key Opinion Leader) interview series covering diverse types of medical institutions and clinical specialties, MediGate News explored the reasons behind adopting HiCardi, the changes observed after its introduction, and expectations for its future direction. HiCardi is developed by Mezoo and marketed by Dong-A ST.



Source: MediGate News (https://www.medigatenews.com/news/595054706)


 

적용 법률 및 규정
의료기기

하이카디® 시스템은 인허가에 따라 신생아, 소아, 청소년, 18세 이상 환자의 ECG 데이터를 측정하여 부정맥을 진단하는 의료기기로서 의료전문가가 사용하도록 설계되었습니다. 한국 KFDA로부터 의료기기 2등급 인증을 받았습니다. 유럽의료기기 지침(2007/47/EC에 따라 개정된 MDD 93/42/EEC)에 따라 준수된 Class IIb (CE2265). 의료기기 제품으로 CE 승인되었습니다. 미국 FDA는 Class II 510K로 승인 완료 예정입니다.

경고

본 자료는 의료 전문가에게만 배포되며 관련 사진과 함께 제공되는 자료와 관련하여 그 어떤 법적인 책임을 갖지 않습니다. 사용 전 사용 지침서를 주의 깊게 읽으십시오.